Indian small pharma firms are struggling with the complex requirements of the new Schedule M rules, with December 31, 2025, looming near. Harish K Jain, director at Embiotic Labs and president of the Federation of Pharmaceutical Entrepreneurs
Germany and Karnataka have decided to increase cooperation in the life sciences sector through collaborative innovation centers, co-sponsored biotech R&D award programs, and joint initiatives in green pharmaceutical manufacturing.
The AI-powered Stryker Mako Robotic System, unveiled by CARE Hospitals in Hitech City, has raised the bar for robotic joint replacement procedures in Telangana.
.jpeg)
To further enhance the global ecosystem of biosimilar, the pharma major Lupin harnessed a strategic step of having a licence and supply deal with the Zentiva Group to commercialise its biosimilar product Certolizumab Pegol in various international te
Kerala has once again been put on high alert, as the state is facing yet another Nipah virus outbreak, and the Centre is taking action. A special joint outbreak response team, with specialists from the National Centre for Disease Control (NCDC)...
Anticipating India's leadership role in BRICS starting 2026, World Health Innovation Forum’s (WHIF) invitation to the BRICS+ Manufacturing Working Group was afforded because of Andhra Pradesh MedTech Zone’s (AMTZ) thought leadership in developing...
Eisai Pharma, a global leader in human healthcare innovation, has announced plans to establish a state-of-the-art Global Capability Centre (GCC) in Visakhapatnam, Andhra Pradesh.
.jpeg){kind=spacer}
The Medical Technology Association of India (MTaI) has strong objections to a recent notification issued by the Maharashtra Medical Council (MMC) that allows homoeopathy practitioners to administer allopathic drugs
India's pharmaceutical sector is undergoing a significant transformation, both in the discovery of new medicines and advancements in drug delivery.
President Donald Trump on Tuesday announced a possible 200% tariff on imported pharmaceuticals. Speaking at a White House cabinet meeting, he said the goal is to push drug companies to make their medicines in the U.S. instead of overse...
, CDSCO.jpg)
